ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update.
Publication Title
J Am Coll Radiol
Document Type
Article
Publication Date
11-1-2022
Keywords
eureka; california; Humans; Liver Neoplasms; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Brachytherapy; Radiologists
Abstract
The treatment and management of hepatic malignancies can be complex because it encompasses a variety of primary and metastatic malignancies and an assortment of local and systemic treatment options. When to use each of these treatments is critical to ensure the most appropriate care for patients. Interventional radiologists have a key role to play in the delivery of a variety of liver directed treatments including percutaneous ablation, transarterial embolization with bland embolic particles alone, transarterial chemoembolization (TACE) with injection of a chemotherapeutic emulsion, and transarterial radioembolization (TARE). Based on 9 clinical variants, the appropriateness of each treatment is described in this document. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances in which peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
Clinical Institute
Cancer
Specialty/Research Institute
Gastroenterology
Specialty/Research Institute
Hepatology
Specialty/Research Institute
Oncology
